Why Investors Should Avoid Energy Stocks
The sudden jump in WTI crude prices after Israel attacked Iran’s nuclear facilities faded quickly. In the last week, prices gave up recent gains. Investors should consider avoiding the sector.Long term energy investors may continue to hold Exxon (XOM), Chevron (CVX), and ConocoPhilips (COP). However, those who did not start a position may want to wait for the volatility to ease. Fear that oil supply disruptions would raise prices lifted energy stocks. That is not a sustainable rally.Energy investors need crude prices to strengthen as demand rises. In the near term, odds are rising that the global economy will slow. The fluctuating tariffs, from a steep imposition to a pause, distorted demand. Shipping activity rose after suppliers exported goods before tariffs. They did so again when the U.S. paused tariffs.If the U.S. lifts the tariff pause, it would weaken the economy. Oil prices would fall in response.While the Middle east tensions eased earlier this week, that might change. A break of the seize fire would lift oil prices again.Starter PositionsInvestors should watch the out-of-favor energy firms. Watch companies including Occidental Petroleum (OXY), Devon Energy (DVN), and Canadian Natural Resources (CNI). On Tuesday, OXY stock fell by 3.34%. Exxon stock fell by 3%.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


